Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.
about
The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and SourceInterleukin-1 beta influences on lysyl oxidases and matrix metalloproteinases profile of injured anterior cruciate ligament and medial collateral ligament fibroblastsResolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injuryChronic lung disease in the preterm infant. Lessons learned from animal modelsPseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1.Transglutaminase 2: a new player in bronchopulmonary dysplasia?Reduction of microRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1.Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasiaThe H2S-generating enzymes cystathionine β-synthase and cystathionine γ-lyase play a role in vascular development during normal lung alveolarization.Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure.Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.Prenatal inflammation exacerbates hyperoxia-induced functional and structural changes in adult mice.Mechanisms of bronchopulmonary dysplasia.VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn miceGlucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.JNK suppresses pulmonary fibroblast elastogenesis during alveolar development.Update in pediatric lung disease 2009.Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia.Altered lung development in bronchopulmonary dysplasia.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia.A three-dimensional human model of the fibroblast activation that accompanies bronchopulmonary dysplasia identifies Notch-mediated pathophysiology.Copper Deficiency in the Lungs of TNF-α Transgenic Mice.Extracellular matrix structure and tissue stiffness control postnatal lung development through the lipoprotein receptor-related protein 5/Tie2 signaling system.Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia.The BPD trio? Interaction of dysregulated PDGF, VEGF, and TGF signaling in neonatal chronic lung disease.Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.Extracellular matrix in lung development, homeostasis and disease.Alterations in expression of elastogenic and angiogenic genes by different conditions of mechanical ventilation in newborn rat lung.BMP7 regulates lung fibroblast proliferation in newborn rats with bronchopulmonary dysplasia.Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.Transcriptome profiling of the newborn mouse lung after hypoxia and reoxygenation: hyperoxic reoxygenation affects mTOR signaling pathway, DNA repair, and JNK-pathway regulation.microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation
P2860
Q26771338-EF7A5A9C-13CA-4741-9E9E-84E1484BF052Q28394792-700FA49A-1E29-4DC9-A8D8-B4482EE943A3Q28539312-4364B0A6-AA49-4282-84A5-F8EB82BD511AQ33756577-A8D1FE86-231F-49F3-AC92-3B57BD5855A0Q33759171-34329AC1-2B7F-4445-A46F-886A18B261EEQ34417656-0CE6415A-CECF-43FD-A53A-0BE71EA7FD47Q34990323-BF29A830-5724-4DDA-B9D5-BDBB852E4989Q35667226-BFC1BD97-0E37-40A7-8D6D-718F32D336CFQ35732676-981A49BE-8AFE-475D-8935-CFD2A4D12F9AQ35994476-025D62BD-0081-46C5-A365-1DDDC7C7F67CQ36108048-A9F5CF0E-3E98-4ADA-A4DC-B140FD9D85DFQ36178520-7D026251-0CE9-4206-A6BD-066E7859FF8CQ36864667-19301DF6-11AD-48C8-8B98-B059084D3CD0Q36923908-3EBCECCA-5FC7-4660-9A8C-833718D1C5B4Q37563414-C9FA9149-CAC2-4F23-96CF-765F70FB95E5Q37576073-14C68D9E-925E-4A84-B0FD-9D94FE61913AQ37704671-B5BCEE65-1B12-43AB-A592-4A053F0BAAA2Q37718407-6BC48D8D-91DA-4D26-929D-9BE0D2B3F174Q38161431-EF09BAB2-B73F-4855-ACB4-7CFA94FE210CQ38196734-C445B631-09E5-468F-B1CC-85F847F8329AQ38271628-A2D2BD2E-B866-4B14-9370-A46BFC01D86EQ38585146-FA7ED9FE-32EA-432E-BF02-460E11E823C0Q41117063-F71E97B0-4842-4751-9C7A-3337E94A7ABCQ42575032-0E50043D-E8B7-4255-B5DA-30C3C87131F2Q42726122-BF20618D-2F30-4DB0-8EE4-1F5EE6F9512EQ45263048-BB19B0E9-04F0-4E53-913B-FA05E11942A6Q45743135-D0F731B5-5186-422E-AE61-2BE159F3BCCEQ46326148-81697D0E-AFCC-4F5A-BBBF-94CBBC029971Q47282071-57BE4956-AD6C-4478-8655-AD3A74CB5CAAQ47755595-774F17AE-9100-4C3A-B490-DC26D73C6E57Q50420061-7CB87EA5-C19D-4B64-B412-782C14208417Q51664555-920DDAE2-AA4D-4616-A17D-1D3EBF64211EQ52728267-BB70B6D3-383B-4A10-8208-F69018E5D741Q53168403-6EF2970F-780A-4C9E-98E0-2673E305FB43Q54245127-CBD8DA69-F76B-47DA-AB26-C81533C755B0Q57395334-95609C0D-9731-46A7-A0B4-E22644CFD51E
P2860
Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@ast
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@en
type
label
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@ast
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@en
prefLabel
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@ast
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@en
P2093
P2860
P50
P1476
Lysyl oxidase activity is dysr ...... tion of mouse and human lungs.
@en
P2093
Alexander H Nave
Arun Kumarasamy
Irene van der Horst
Irwin Reiss
Isabelle Schmitt
Jesse D Roberts
Oliver Eickelberg
Ronald R de Krijger
P2860
P304
P356
10.1164/RCCM.200902-0215OC
P407
P577
2009-09-24T00:00:00Z